July 30, 2023
1 min watch
Save
VIDEO: Ocuphire official previews company’s next steps
SEATTLE — In this Healio Video Perspective from OIS Retina, Ronil Patel, MS, discusses Ocuphire Pharma’s end-of-phase 2 FDA meeting planned for later this year.
Patel also previews two upcoming presentations on the safety and efficacy of APX3330, an oral drug candidate for diabetic retinopathy.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Patel reports being senior vice president of operations and business development at Ocuphire Pharma.
Read more about